Phase II study of gemcitabine plus oxaliplatin as first-line chemotherapy for advanced non-small-cel...
Phase II study of gemcitabine plus oxaliplatin as first-line chemotherapy for advanced non-small-cell lung cancer
About this item
Full title
Author / Creator
Cappuzzo, F , Novello, S , De Marinis, F , Franciosi, V , Maur, M , Ceribelli, A , Lorusso, V , Barbieri, F , Castaldini, L , Crucitta, E , Marini, L , Bartolini, S , Scagliotti, G V and Crinò, L
Publisher
London: Nature Publishing Group UK
Journal title
Language
English
Formats
Publication information
Publisher
London: Nature Publishing Group UK
Subjects
More information
Scope and Contents
Contents
This phase II study evaluated the response rate and tolerability of gemcitabine–oxaliplatin chemotherapy in non-small-cell lung cancer (NSCLC) patients. Chemonaive patients with stage IIIB or IV NSCLC received gemcitabine 1000 mg m
−2
on days 1 and 8, followed by oxaliplatin 130 mg m
−2
on day 1. Cycles were repeated every 21 days for u...
Alternative Titles
Full title
Phase II study of gemcitabine plus oxaliplatin as first-line chemotherapy for advanced non-small-cell lung cancer
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2361475
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2361475
Other Identifiers
ISSN
0007-0920
E-ISSN
1532-1827
DOI
10.1038/sj.bjc.6602667
